Chris O’Brien

Elagolix, an Oral GnRH Antagonist, Versus Subcutaneous Depot Medroxyprogesterone Acetate for the Treatment of Endometriosis: Effects on Bone Mineral Density

Bruce R. Carr, W. Paul Dmowski, Chris O’Brien et al. · Reproductive Sciences · 2014 · 113 citations · Full text

Medicine, Endocrinology, Gynecology +16

Ustekinumab Pharmacokinetics and Exposure Response in a Phase 3 Randomized Trial of Patients With Ulcerative Colitis

Omoniyi J. Adedokun, Zhenhua Xu, Colleen Marano et al. · Clinical Gastroenterology and Hepatology · 2019 · 106 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Single Night Studies in Obstructive Sleep Apnea

Conrad Iber, Chris O’Brien, Jan Schluter et al. · SLEEP · 1991 · 71 citations · Full text

Medicine, Respiratory Therapy, Pulmonary Function Testing +16

A Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of 2 Dosing Regimens of Fostamatinib in Patients with Rheumatoid Arthritis with an Inadequate Response to a Tumor Necrosis Factor-α Antagonist

Mark C. Genovese, D. M. van der HEIJDE, Edward C. Keystone et al. · The Journal of Rheumatology · 2014 · 67 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Elagolix, an Oral GnRH Antagonist for Endometriosis-Associated Pain: A Randomized Controlled Study

Bruce R. Carr, Linda C. Giudice, W. Paul Dmowski et al. · Journal of Endometriosis and Pelvic Pain Disorders · 2013 · 63 citations · Full text

Medicine, Gynecology, Pharmacotherapy +17